Search Results
Results found for "Scott Struthers"
- 📰 GPCR Weekly News, June 17 to 23, 2024
and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103 Industry News EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
Papasergi-Scott and colleagues has made significant progress in this area 2. Papasergi-Scott, M. M. et al. Time-resolved cryo-EM of G-protein activation by a GPCR.
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
(“Neurocrine Biosciences”) announced 22 November 2021, the applicable waiting period under the Hart-Scott-Rodino
- From DNA day to GPCR genomics
Current opinion in structural biology, 55, 161–177. https://doi.org/10.1016/j.sbi.2019.04.007 Papasergi-Scott
- 📰 GPCR Weekly News, March 11 to 17, 2024
This week's highlight includes congrats to: Makaía M Papasergi-Scott, Peter Gmeiner, Brian K Kobilka,
- 📰 GPCR Weekly News, February 12 to 18, 2024
Dylan Scott Eiger, Chloe Hicks, Dr.
- Molecular creativity in drug discovery
Whether you’re designing the next assay, scouting a new therapeutic angle, or exploring career pivots
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
This is where funders, peers, and biotech scouts are watching.
